Mirum Pharmaceuticals, Inc. MIRM EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s EPS (diluted)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported EPS (diluted) of -$13.43 in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s EPS (diluted) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s EPS (diluted) decreased by 4376.7% year-over-year, from -$0.30 to -$13.43.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s EPS (diluted)?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s EPS (diluted) has grown at a -50.4% compound annual growth rate (CAGR), from -$4.02 to -$0.49.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.